2750534-84-8
2750534-84-8
Chemical Structure
Oclacitinib-13C-d3
- CAS No.: 2750534-84-8
- Formula:C1413CH20D3N5O2S
- Molecular Weight:341.45
IUPAC Name: N-methyl-1-((1r,4r)-4-((methyl-13C-d3)(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide
InChIKey: HJWLJNBZVZDLAQ-JWRHSUTGSA-N
SMILES: CNS(C[C@@H]1CC[C@H](CC1)N([13C]([2H])([2H])[2H])C2=NC=NC3=C2C=CN3)(=O)=O
Biological Activity: Oclacitinib-13C-d3 is the deuterium and 13C labeled Oclacitinib[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oclacitinib-13C-d3 | 99.15% | Oclacitinib-13C-d3 is the deuterium and 13C labeled Oclacitinib. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oclacitinib | 99.03% | Oclacitinib is a novel JAK inhibitor. Oclacitinib is most potent at inhibiting JAK1 (IC50=10 nM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
